In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393): A novel orally administered cephalosporin
- 31 October 1991
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 14 (5), 425-434
- https://doi.org/10.1016/0732-8893(91)90069-r
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1990
- Biochemical characteristics of extended broad spectrum β-lactamasesInfection, 1989
- Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1989
- Preliminary in-vitro studies of BMY-28232, the active metabolite of the BMY-28271 cephalosporin esterJournal of Antimicrobial Chemotherapy, 1989
- Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against Enterococcus faecalisDiagnostic Microbiology and Infectious Disease, 1989
- Susceptibility of stably derepressed beta-lactamase producing strains to imipenem and four quinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Antimicrobial activity, spectrum and pharmacokinetics of old and new orally administered cephemsAntimicrobic Newsletter, 1988
- In vitro antibacterial activity of FK482, a new orally active cephalosporin.The Journal of Antibiotics, 1988
- FK 482, a new orally active cephalosporin. Synthesis and biological properties.The Journal of Antibiotics, 1988
- Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibioticsDiagnostic Microbiology and Infectious Disease, 1987